Andromeda Surgical envisions a future where surgeons aren't performing tedious tasks but orchestrating multiple autonomous surgeries at a high level. This shifts their role from practitioner to overseer, increasing efficiency and accessibility while keeping a human in the loop.
Andromeda Surgical chose urology as its wedge market not because the procedure was simple, but because urologists were early adopters of the DaVinci robot. This pre-existing cultural acceptance of technology de-risks market entry and accelerates adoption.
Despite scarcer data, the surgical environment is more bounded and predictable than public roads. It lacks "adversarial actors" like other cars or pedestrians, making the path to full autonomy potentially less complex and faster to achieve than for self-driving vehicles.
Andromeda's strategy for FDA approval involves submitting a series of small, incremental software updates rather than one large, high-stakes submission for full autonomy. This makes each review more manageable for regulators and builds regulatory comfort over time.
By releasing new software features weekly based on direct feedback from surgeons in the clinic, Andromeda has compressed the typical multi-year MedTech development cycle into weeks. This rapid, customer-centric improvement loop is shocking to the traditionally slow-moving medical industry.
Andromeda Surgical accelerates its development by using a commodity robotic arm from KUKA. This strategy allows them to focus resources on their core IP—the AI and software autonomy layer—rather than sinking capital and time into custom hardware development.
While public surgical videos from YouTube can bootstrap initial models, Andromeda's defensible data moat is built from capturing proprietary data during live procedures. This includes robot kinematics and force feedback, which is impossible to source elsewhere and essential for training autonomy.
To de-risk investments and prevent surprise cash calls, PropTech platform Mogul includes a 12-month vacancy reserve in each property's initial fundraising. This ensures the asset can sit completely empty for a year without requiring additional funds from its fractional owners.
Mogul's revenue model includes a 5% platform fee from investors plus an additional 1.5-2% fee paid by the property seller. By acting as its own buyer's broker, the platform taps into a second revenue stream that doesn't dilute investor returns.
Mogul highlights how real estate depreciation, a non-cash "ghost expense," can offset rental income for tax purposes. This allows investors to receive an 8-12% annual cash dividend that is often treated as a passive loss, making it effectively tax-free.
To solve the illiquidity of fractional real estate, Mogul plans to launch a secondary market where it acts as the initial market maker. It will buy shares from sellers, using the property's strong rental income to service any debt required to provide that liquidity.